| Items | Drug Registration information |
|---|---|
| ID | 281 |
| No | 281 |
| Brand Name | WELIDX |
| Ingredients | BELZUTIFAN 40 MG |
| Dosage Form | FILM COATED TABLET |
| Primary Packaging | BOTTLE |
| Storage | |
| Shelf Life | 2 YEARS |
| Pack Size | BOX OF 56'S/BOTTLE |
| Dispensing Category | |
| ATC Classification | |
| Pharmaceutical Class | |
| Indications | FOR THE TREATMENT OF ADULT PATIENTS WITH VON HIPPEL-LINDAU DISEASE WHO REQUIRE THERAPY FOR ASSOCIATED RENAL CELL CARCINOMA, CENTRAL NERVOUS SYSTEM HEMANGIOBLASTOMAS, OR PANCREATIC NEUROENDROCRINE TUMORS, NOT REQUIRING IMMIDIATE SURGERY |
| Contraindications | |
| Side Effects | |
| Unit Price | |
| EDL | NULL |
| Description | BLUE TABLET |
| Note | |
| License Owner | BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
| Manufacturer | BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
| Country | LAOS |
| Import Registration No | |
| Import Registration Date | |
| Activity | CERTIFICATE RELEASED |
| Applied Date | |
| FDD Registration No | 09 L 1208/24 |
| FDD Registration Date | 03/10/2024 |
| Expiry Date | 02/10/2029 |